Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142740 |
| CAS No | NA |
| Mol.F. | C15H9ClN3O5 |
| Mol.Wt. | 347.71g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142741 |
| CAS No | NA |
| Mol.F. | C30H20Cl2N6O9 |
| Mol.Wt. | 679.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142742 |
| CAS No | NA |
| Mol.F. | C21H23N3O5S |
| Mol.Wt. | 429.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142743 |
| CAS No | NA |
| Mol.F. | C20H21N3O5S |
| Mol.Wt. | 415.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142744 |
| CAS No | NA |
| Mol.F. | C18H16N2O5S |
| Mol.Wt. | 372.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142745 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142746 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142747 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142748 |
| CAS No | NA |
| Mol.F. | C17H17NO3S |
| Mol.Wt. | 344.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142749 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142750 |
| CAS No | NA |
| Mol.F. | C19H21N3O4S |
| Mol.Wt. | 387.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142751 |
| CAS No | NA |
| Mol.F. | C13H11N3O4S |
| Mol.Wt. | 305.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142752 |
| CAS No | NA |
| Mol.F. | C14H13N3O4S |
| Mol.Wt. | 319.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142753 |
| CAS No | NA |
| Mol.F. | C24H32N2O12S |
| Mol.Wt. | 601.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142754 |
| CAS No | NA |
| Mol.F. | C12H11N3O4S |
| Mol.Wt. | 293.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142755 |
| CAS No | NA |
| Mol.F. | C24H21N5O5S2 |
| Mol.Wt. | 523.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |